This company seems to have been delisted
Reason: Acquired by Johnson & Johnson
Last recorded trade on: August 1, 2024
Source: https://www.jnj.com/media-center/press-releases/johnson-johnson-completes-acquisition-of-abiomed
Reason: Acquired by Johnson & Johnson
Last recorded trade on: August 1, 2024
Source: https://www.jnj.com/media-center/press-releases/johnson-johnson-completes-acquisition-of-abiomed
Abiomed
ABMD
£294.30
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the world’s smallest heart pump.
Abiomed (ABMD) - Total debt
Total debt on the balance sheet as of March 2018 : N/A
According to Abiomed's latest financial reports the company's total debt is N/A. A company’s total debt is the sum of all current and non-current debts.
Abiomed - Total debt on balance sheet (from 2016 to 2018)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2018-03-31 | N/A | -100% |
| 2017-03-31 | £13.09 M | |
| 2002-03-31 | £0.03 M | -77.84% |
| 2001-03-31 | £0.17 M | 15.48% |
| 2000-03-31 | £0.14 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | £1.35 B | N/A | 🇺🇸 USA |
 | £8.60 B | N/A | 🇺🇸 USA |
 | £59.11 M | N/A | 🇺🇸 USA |